Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.K. To Begin Clinical, Cost-Effectiveness Device Assessments Next Month

This article was originally published in The Gray Sheet

Executive Summary

Britain's National Institute of Clinical Excellence (NICE) plans to conduct on an annual basis clinical and cost-effectiveness evaluations of between 30 and 50 new and existing medical technologies, Edward Hutt, division director Quintiles Medical Technology Consultants, said March 14.

You may also be interested in...



European Tech Assessments Linked To Health Care Budget Mechanisms

Political health care spending decisions and recent recommendations by medical technology assessment bodies appear to be closely linked in certain European countries, industry officials at a May 9 session of the Deutsche Banc Alex. Brown health care conference in Baltimore observed.

European Tech Assessments Linked To Health Care Budget Mechanisms

Political health care spending decisions and recent recommendations by medical technology assessment bodies appear to be closely linked in certain European countries, industry officials at a May 9 session of the Deutsche Banc Alex. Brown health care conference in Baltimore observed.

UK's NICE Could Issue ICD Guidance As Early As Sept. 25 - ABHI Officials

The National Institute for Clinical Excellence (NICE) guidance to the UK's National Health Service focusing on the clinical and cost effectiveness of implantable cardioverter defibrillators (ICDs) could be issued as early as the week of Sept. 25.

Related Content

UsernamePublicRestriction

Register

MT011513

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel